SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-333910
Filing Date
2013-08-14
Accepted
2013-08-14 10:04:33
Documents
3
Period of Report
2013-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d584451d8k.htm 8-K 17033
2 EX-99.1 d584451dex991.htm EX-99.1 74226
3 GRAPHIC g584451g15t58.jpg GRAPHIC 11358
  Complete submission text file 0001193125-13-333910.txt   108333
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54910 | Film No.: 131035453
SIC: 2834 Pharmaceutical Preparations